Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA, Uhm JH, Jaeckle KA, Choucair A, Flynn PJ, Yung WKA, Prados MD, Bruner JM, Chang SM, Kyritsis AP, Gleason MJ, Hess KR. Levin VA, et al. Among authors: kyritsis ap. Clin Cancer Res. 2000 Oct;6(10):3878-84. Clin Cancer Res. 2000. PMID: 11051233 Clinical Trial.
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme.
Levin VA, Maor MH, Thall PF, Yung WK, Bruner J, Sawaya R, Kyritsis AP, Leeds N, Woo S, Rodriguez L, et al. Levin VA, et al. Among authors: kyritsis ap. Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):357-64. doi: 10.1016/0360-3016(95)00160-Z. Int J Radiat Oncol Biol Phys. 1995. PMID: 7673023 Clinical Trial.
Gamma-ray mutagen sensitivity and survival in patients with glioma.
Sigurdson AJ, Bondy ML, Hess KR, Toms SA, Kyritsis AP, Gu J, Wang LE, Wang X, Adatto P, Bruner JL, Yung WK, Levin VA, Wei Q. Sigurdson AJ, et al. Among authors: kyritsis ap. Clin Cancer Res. 1998 Dec;4(12):3031-5. Clin Cancer Res. 1998. PMID: 9865917
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.
Groves MD, Maor MH, Meyers C, Kyritsis AP, Jaeckle KA, Yung WK, Sawaya RE, Hess K, Bruner JM, Peterson P, Levin VA. Groves MD, et al. Among authors: kyritsis ap. Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):127-35. doi: 10.1016/s0360-3016(99)00122-4. Int J Radiat Oncol Biol Phys. 1999. PMID: 10477016 Clinical Trial.
306 results